Edition:
United States

People: Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

3.85USD
4:00pm EDT
Change (% chg)

$0.05 (+1.32%)
Prev Close
$3.80
Open
$3.80
Day's High
$3.90
Day's Low
$3.80
Volume
14,625
Avg. Vol
29,244
52-wk High
$5.00
52-wk Low
$2.25

Levine, Zurit 

Dr. Zurit Levine, Ph.D., is Vice President - Research and Discovery of Compugen Ltd., since 2011. She joined Compugen in 1999 and has held several positions in Compugen’s Research & Development department. In 2004, she was appointed Director of Therapeutic Selection & Validation, which position she held until 2007 when she was appointed Director of Therapeutic Discovery. In 2009, she was appointed Executive Director of Research & Development. From January 2010 to August 2011, she held the position of Vice President, Research and Development. In August 2011 she was appointed Vice President, Research and Discovery. Dr. Levine holds a B.Sc. in Biology, an M.Sc. in Biochemistry and a Ph.D. in Biochemistry, all from the Tel Aviv University, Israel.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --